HHS grants support healthcare disaster readiness

Laura Pedulli | | Health Exec | Precision Medicine

The Department of Health and Human Services has awarded more than $840 million in grants to public health and healthcare systems for emergency preparedness.

The grant funds are distributed through two federal preparedness programs: the Hospital Preparedness Program (HPP) and the Public Health Emergency Preparedness (PHEP).

Administered by the Office of the Assistant Secretary for Preparedness and Response, HPP funding supports the building of community healthcare coalitions that collaborate on emergency planning and, during disasters, share resources and partner to meet the health and medical needs of their community.

HPP and PHEP funding helps recipients build and sustain public health and healthcare preparedness capabilities, which include establishment of core capabilities, such as medical surge, information sharing and emergency operations.

This marks the third year that HPP and PHEP are awarding funds jointly. Learn more about the programs here.

 

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.